Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
EBAY
|
Rebecca Spencer
VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,412 Added 25.13% |
-
|
Dec 15
2024 |
|
EBAY
|
Rebecca Spencer
VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 912 Reduced 12.69% |
$58,222
$63.84 p/Share
|
Dec 15
2024 |
|
AZEK
|
Sandra Lamartine
CHRO |
BUY
Grant, award, or other acquisition
|
Direct | 2,523 Added 10.72% |
-
|
Dec 15
2024 |
|
AZEK
|
Rakesh Mohan
Chief Digital & Tech. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,449 Added 10.19% |
-
|
Dec 15
2024 |
|
OMCL
|
Randall A Lipps
CHAIRMAN, PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,202 Reduced 2.57% |
$193,334
$46.01 p/Share
|
Dec 15
2024 |
|
AZEK
|
Jonathan Skelly
Pres. Res. & Comm. |
BUY
Grant, award, or other acquisition
|
Direct | 5,373 Added 2.69% |
-
|
Dec 15
2024 |
|
AZEK
|
Samara Toole
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,337 Added 11.3% |
-
|
Dec 15
2024 |
|
OMCL
|
Corey J Manley
EVP&CHIEF LEGAL/ADMIN OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 222 Reduced 0.45% |
$10,214
$46.01 p/Share
|
Dec 15
2024 |
|
EBS
|
Simon C Lowry
SVP, R&D, CMO |
BUY
Grant, award, or other acquisition
|
Direct | 29,482 Added 50.0% |
-
|
Dec 15
2024 |
|
AZEK
|
Morgan Walbridge
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,154 Added 11.6% |
-
|
Dec 15
2024 |
|
NTNX
|
Rajiv Ramaswami
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 132,336 Added 14.64% |
-
|
Dec 15
2024 |
|
NTNX
|
Rajiv Ramaswami
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 58,415 Reduced 7.57% |
$3,858,310
$66.05 p/Share
|
Dec 15
2024 |
|
OMIC
|
Andrew Spaventa
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 486 Added 37.47% |
-
|
Dec 15
2024 |
|
NRG
|
Lawrence S Coben
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 35,189 Reduced 8.47% |
-
|
Dec 15
2024 |
|
AZEK
|
Jesse G Singh
CEO and President |
BUY
Grant, award, or other acquisition
|
Direct | 19,857 Added 2.06% |
-
|
Dec 15
2024 |
|
NTNX
|
Rukmini Sivaraman
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 21,341 Added 9.09% |
-
|
Dec 15
2024 |
|
NTNX
|
Rukmini Sivaraman
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,818 Reduced 5.07% |
$714,528
$66.05 p/Share
|
Dec 15
2024 |
|
AZEK
|
Peter G Clifford
CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct | 7,009 Added 9.53% |
-
|
Dec 15
2024 |
|
OKTA
|
Shibu Ninan
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,235 Added 25.8% |
-
|
Dec 15
2024 |
|
OKTA
|
Shibu Ninan
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,641 Reduced 15.34% |
-
|
Dec 15
2024 |
|
LESL
|
Naomi Cramer
Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,591 Added 26.91% |
-
|
Dec 15
2024 |
|
LESL
|
Naomi Cramer
Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,696 Reduced 8.73% |
$6,578
$2.44 p/Share
|
Dec 15
2024 |
|
OKTA
|
Larissa Schwartz
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,078 Added 21.02% |
-
|
Dec 15
2024 |
|
OKTA
|
Larissa Schwartz
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,590 Reduced 12.29% |
-
|
Dec 15
2024 |
|
OKTA
|
Brett Tighe
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,369 Added 11.43% |
-
|
Dec 15
2024 |
|
OKTA
|
Brett Tighe
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,114 Reduced 4.94% |
-
|
Dec 15
2024 |
|
OMIC
|
Eli N. Glezer
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 250 Added 0.16% |
-
|
Dec 15
2024 |
|
OMIC
|
Dalen Meeter
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 209 Added 2.27% |
-
|
Dec 15
2024 |
|
SEZNL
|
Amin Sabzivand
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 86 Reduced 0.18% |
$26,574
$309.01 p/Share
|
Dec 15
2024 |
|
OKTA
|
Jonathan James Addison
Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,812 Reduced 23.36% |
-
|
Dec 15
2024 |
|
OKTA
|
Jonathan James Addison
Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,278 Added 34.1% |
-
|
Dec 15
2024 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 1,008 Reduced 23.37% |
-
|
Dec 15
2024 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,692 Added 42.77% |
-
|
Dec 15
2024 |
|
OKTA
|
Todd Mc Kinnon
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,730 Reduced 50.68% |
-
|
Dec 15
2024 |
|
OKTA
|
Todd Mc Kinnon
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 17,225 Added 60.93% |
-
|
Dec 15
2024 |
|
TWLO
|
Andrew Stafman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 749 Added 6.94% |
-
|
Dec 15
2024 |
|
ORIC
|
Jacob Chacko
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 67,000 Added 7.7% |
-
|
Dec 15
2024 |
|
ORIC
|
Pratik S Multani
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 24,042 Added 30.18% |
-
|
Dec 15
2024 |
|
LIVN
|
Alex Shvartsburg
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 229 Reduced 1.18% |
$11,793
$51.5 p/Share
|
Dec 15
2024 |
|
LIVN
|
Alex Shvartsburg
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 613 Added 3.07% |
-
|
Dec 15
2024 |
|
LIVN
|
James Christopher Barry
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 353 Reduced 20.66% |
$18,179
$51.5 p/Share
|
Dec 15
2024 |
|
LIVN
|
James Christopher Barry
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,709 Added 50.0% |
-
|
Dec 15
2024 |
|
LIVN
|
Franco Poletti
President, Cardiopulmonary |
SELL
Payment of exercise price or tax liability
|
Direct | 416 Reduced 5.45% |
$21,424
$51.5 p/Share
|
Dec 15
2024 |
|
LIVN
|
Franco Poletti
President, Cardiopulmonary |
BUY
Exercise of conversion of derivative security
|
Direct | 967 Added 11.24% |
-
|
Dec 15
2024 |
|
LIVN
|
Michael Damon Hutchinson
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 784 Reduced 17.27% |
$40,376
$51.5 p/Share
|
Dec 15
2024 |
|
LIVN
|
Michael Damon Hutchinson
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,254 Added 33.18% |
-
|
Dec 15
2024 |
|
ORIC
|
Dominic Piscitelli
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 24,042 Added 17.22% |
-
|
Dec 15
2024 |
|
DOUG
|
Daniel A. Sachar |
SELL
Payment of exercise price or tax liability
|
Direct | 12,198 Reduced 10.62% |
$24,517
$2.01 p/Share
|
Dec 15
2024 |
|
DOUG
|
J Bryant Kirkland Iii |
SELL
Payment of exercise price or tax liability
|
Direct | 76,369 Reduced 7.42% |
$153,501
$2.01 p/Share
|
Dec 15
2024 |
|
ADBE
|
Jillian Forusz
SVP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 387 Reduced 11.74% |
$180,222
$465.69 p/Share
|
Dec 15
2024 |